Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma. | Leukemia | 2023 | 36352190 | PubTator, text mining | PubMed |
| Allogeneic Hematopoietic Cell Transplantation after Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma. | Transplant Cell Ther | 2023 | 36343892 | PubTator, text mining | PubMed |
| Genomic Profiling Reveals Differences in Primary Central Nervous System Lymphoma and Large B-Cell Lymphoma, With Subtyping Suggesting Sensitivity to BTK Inhibition. | Oncologist | 2023 | 36342081 | PubTator, text mining | PubMed |
| Waldenström macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations. | Blood Adv | 2023 | 36332058 | PubTator, text mining | PubMed |
| CVID-Associated B Cell Activating Factor Receptor Variants Change Receptor Oligomerization, Ligand Binding, and Signaling Responses. | J Clin Immunol | 2023 | 36308663 | PubTator, text mining | PubMed |
| Recent advances in cutaneous lymphoma-implications for current and future classifications. | Virchows Arch | 2023 | 36278991 | PubTator, text mining | PubMed |
| An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas. | Cancer Discov | 2023 | 36264161 | PubTator, text mining | PubMed |
| Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes. | J Clin Endocrinol Metab | 2023 | 36262060 | PubTator, text mining | PubMed |
| Targeting lipid-protein interaction to treat Syk-mediated acute myeloid leukemia. | Nat Chem Biol | 2023 | 36229686 | PubTator, text mining | PubMed |
| Intravascular Large B-Cell Lymphoma Genomic Profile Is Characterized by Alterations in Genes Regulating NF-κB and Immune Checkpoints. | Am J Surg Pathol | 2023 | 36221796 | PubTator, text mining | PubMed |
| Remodelling landscape of tissue-engineered bladder with porcine small intestine submucosa using single-cell RNA sequencing. | Cell Prolif | 2023 | 36177893 | PubTator, text mining | PubMed |
| Disease-Defining Molecular Features of Primary Cutaneous B-Cell Lymphomas: Implications for Classification and Treatment. | J Invest Dermatol | 2023 | 36163302 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens identify ferroptosis as a novel therapeutic vulnerability in acute lymphoblastic leukemia. | Haematologica | 2023 | 36134452 | PubTator, text mining | PubMed |
| A structural platform for B cell receptor signaling. | Cell Res | 2023 | 36109597 | PubTator, text mining | PubMed |
| First description of the t(3;17)(q27;q21)/IGF2BP2::LSM12 translocation in marginal zone lymphoma. | Blood Adv | 2023 | 36095303 | PubTator, text mining | PubMed |
| Resistance to Bruton tyrosine kinase inhibition in chronic lymphocytic leukaemia and non-Hodgkin lymphoma. | Br J Haematol | 2023 | 36029036 | PubTator, text mining | PubMed |
| Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies. | Cancer Immunol Immunother | 2023 | 35963895 | PubTator, text mining | PubMed |
| Follicular lymphoma: The long and winding road leading to your cure? | Blood Rev | 2023 | 35908982 | PubTator, text mining | PubMed |
| Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL. | Blood Adv | 2023 | 35901280 | PubTator, text mining | PubMed |
| Refractory Primary Vitreoretinal Lymphoma Involving the Spinal Cord with a Temporary Complete Response to Tirabrutinib. | Intern Med | 2023 | 35793963 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=45